FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pär Stattin

Research Profile

Disorders

Geographic Areas

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Sigrid Carlsson; Katja Fall; Mats Lambe; Fredrik Sandin; Pär Stattin; Jan Adolfsson; Anna Bill-Axelson
Risk of suicide in men with low-risk prostate cancer.
Sandra Eloranta; Paul C Lambert; Pär Stattin; Jan Adolfsson; Olof Akre; Therese M-L Andersson; Paul W Dickman
How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
Stacy Loeb; David Robinson; Sigrid Carlsson; Linda Drevin; Erik Holmberg; Mats Lambe; Pär Stattin
Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pär Stattin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sigrid Carlsson; Katja Fall; Mats Lambe; Fredrik Sandin; Pär Stattin; Jan Adolfsson; Anna Bill-Axelson
Risk of suicide in men with low-risk prostate cancer.
European journal of cancer (Oxford, England : 1990) 2013;49(7):1588-99.
2013: Sandra Eloranta; Paul C Lambert; Pär Stattin; Jan Adolfsson; Olof Akre; Therese M-L Andersson; Paul W Dickman
How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
Cancer causes & control : CCC 2013;24(3):505-15.
2013: Stacy Loeb; David Robinson; Sigrid Carlsson; Linda Drevin; Erik Holmberg; Mats Lambe; Pär Stattin
Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.
Cancer causes & control : CCC 2013;24(2):383-90.
2013: Mieke Van Hemelrijck; Olof Akre; Anna Bill-Axelson; Stefan Carlsson; Hans Garmo; Lars Holmberg; Pär Stattin; Jan Adolfsson
Thromboembolic events following surgery for prostate cancer.
European urology 2013;63(2):354-63.
2013: Christel Häggström; Göran Hallmans; Håkan Jonsson; Börje Ljungberg; Jonas Manjer; Gabriele Nagel; Kilian Rapp; Randi Selmer; Martin Almqvist; Tone Bjørge; Hans Concin; Anders Engeland; Tanja Stocks; Steinar Tretli; Hanno Ulmer; Pär Stattin
Metabolic factors associated with risk of renal cell carcinoma.
PloS one 2013;8(2):e57475.
2013: Susanne Strohmaier; Steinar Tretli; Martin Almquist; Tone Bjørge; Wegene Borena; Hans Concin; Michael Edlinger; Anders Engeland; Christel Häggström; Göran Hallmans; Håkan Jonsson; Jonas Manjer; Gabriele Nagel; Randi Selmer; Pär Stattin; Tanja Stocks; Hanno Ulmer
Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).
PloS one 2013;8(1):e54242.
2013: Björn Lindkvist; Gabriele Nagel; Randi Selmer; Pär Stattin; Tanja Stocks; Steinar Tretli; Martin Almquist; Tone Bjørge; Wegene Borena; Guenter Diem; Anders Engeland; Christel Häggström; Göran Hallmans; Dorthe Johansen; Håkan Jonsson; Jonas Manjer
Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).
Cancer causes & control : CCC 2013;24(1):107-16.
2013: Jennifer R Rider; Fredrik Sandin; Ove Andrén; Jonas Hugosson; Peter Wiklund; Pär Stattin
Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.
European urology 2013;63(1):88-96.
2012: Christel Häggström; Göran Hallmans; Håkan Jonsson; Jonas Manjer; Gabriele Nagel; Randi Selmer; Martin Almqvist; Tone Bjørge; Hans Concin; Anders Engeland; Tanja Stocks; Steinar Tretli; Hanno Ulmer; David Ulmert; Pär Stattin
Prospective study on metabolic factors and risk of prostate cancer.
Cancer 2012;118(24):6199-206.
2012: Mieke Van Hemelrijck; Jan Adolfsson; Linda Drevin; Hans Garmo; Lars Holmberg; Pär Stattin
Primary cancers before and after prostate cancer diagnosis.
Cancer 2012;118(24):6207-16.
2012: Stefan Carlsson; Ola Bratt; Pär Stattin; Lars Egevad
Current routines for transrectal ultrasound-guided prostate biopsy: a web-based survey by the Swedish Urology Network.
Scandinavian journal of urology and nephrology 2012;46(6):405-10.
2012: Jon Fridriksson; Katarina Gunseus; Pär Stattin
Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the National Prostate Cancer Register (NPCR) of Sweden.
Scandinavian journal of urology and nephrology 2012;46(5):326-31.
2012: Gabriele Nagel; Randi Selmer; Daniela Späth; Pär Stattin; Tanja Stocks; Hanno Ulmer; Tone Bjørge; Hans Concin; Anders Engeland; Christel Häggström; Göran Hallmans; Anette Hjartåker; Håkan Jonsson; Björn Lindkvist; Jonas Manjer; Richard F Schlenk
Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can).
Annals of hematology 2012;91(10):1519-31.
2012: K Fredrik Jansson; Pär Stattin; Hans Garmo; Jan Adolfsson; Olof Akre; Anna Bill-Axelson; Ola Bratt
Concordance of tumor differentiation among brothers with prostate cancer.
European urology 2012;62(4):656-61.
2012: Andreas Josefsson; Lars Karlberg; Pär Stattin; Pernilla Wikström; Lars Egevad; Torvald Granfors; Anders Bergh
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Scandinavian journal of urology and nephrology 2012;46(4):247-57.
2012: Andreas Thorstenson; Olof Akre; Anna Bill-Axelson; Ola Bratt; Henrik Hellborg; Lars Holmberg; Mats Lambe; Pär Stattin; Jan Adolfsson
Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden.
European journal of cancer (Oxford, England : 1990) 2012;48(11):1672-81.
2012: Wegene Borena; Hans Concin; Michael Edlinger; Anders Engeland; Christel Häggström; Goran Hallmans; Håkan Jonsson; Björn Lindkvist; Annekatrin Lukanova; Jonas Manjer; Gabriele Nagel; Randi Selmer; Pär Stattin; Tanja Stocks; Susanne Strohmaier; Steinar Tretli; Tone Bjørge; Hanno Ulmer
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
International journal of cancer. Journal international du cancer 2012;131(1):193-200.
2012: Sara Wirén; Pär Stattin
[Research on quality registries provides clinical benefit. Results from the National Prostate Cancer Registry].
Läkartidningen 2012;109(26-28):1294-7.
2012: Hanno Ulmer; Randi Selmer; Pär Stattin; Tanja Stocks; Steinar Tretli; Martin Almquist; Tone Bjørge; Wegene Borena; Hans Concin; Anders Engeland; Christel Häggström; Göran Hallmans; Håkan Jonsson; Andrea Kleiner; Annekatrin Lukanova; Jonas Manjer; Gabriele Nagel
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
Gynecologic oncology 2012;125(2):330-5.
2012: Tanja Stocks; Steinar Tretli; Hanno Ulmer; Mieke Van Hemelrijck; Tone Bjørge; Hans Concin; Anders Engeland; Göran Hallmans; Håkan Jonsson; Björn Lindkvist; Jonas Manjer; Gabriele Nagel; Randi Selmer; Pär Stattin
Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project.
Hypertension 2012;59(4):802-10.
2012: Mieke Van Hemelrijck; Hans Garmo; Lars Holmberg; Pär Stattin; Jan Adolfsson
Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden.
European urology 2012;61(4):690-700.
2012: Mattias Johansson; Pär Stattin
Guidelines are too important to be left to clinical experts.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2012;184(2):159-60.
2012: Michael Edlinger; Anders Engeland; Christel Häggström; Göran Hallmans; Dorthe Johansen; Håkan Jonsson; Jonas Manjer; Gabriele Nagel; Randi Selmer; Pär Stattin; Tanja Stocks; Susanne Strohmaier; Steinar Tretli; Tone Bjørge; Wegene T Borena; Hans Concin; Hanno Ulmer
Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study.
Journal of hypertension 2012;30(2):290-6.
2012: Peter Hammarsten; Andreas Josefsson; Pär Stattin; Mariateresa Cipriano; Lars Egevad; Torvald Granfors; Christopher J Fowler
Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
PloS one 2012;7(10):e47994.
2012: Robert Szulkin; Jianfeng Xu; Sigun Zheng; Henrik Grönberg; Erik Holmberg; Juni Palmgren; Pär Stattin; Fredrik Wiklund
Prostate cancer risk variants are not associated with disease progression.
The Prostate 2012;72(1):30-9.
2012: Mattias Johansson; Ulf-Håkan Stenman; Fredrik Wiklund; Anders Bergh; Göran Hallmans; Sally R Hinchliffe; Benny Holmström; Pär Stattin
Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study.
International journal of cancer. Journal international du cancer 2012;130(1):129-37.
2011: Tone Bjørge; Hans Concin; Martin Almquist; Christel Häggström; Göran Hallmans; Håkan Jonsson; Annekatrin Lukanova; Jonas Manjer; Gabriele Nagel; Randi Selmer; Pär Stattin; Tanja Stocks; Steinar Tretli; Hanno Ulmer; Anders Engeland
Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
International journal of epidemiology 2011;40(6):1667-77.
2011: Håkan Jonsson; Stephen W Duffy; Benny Holmström; Pär Stattin
Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden.
International journal of cancer. Journal international du cancer 2011;129(8):1881-8.
2011: Andreas Josefsson; Anna Engström Laurent; Pär Stattin; Pernilla Wikström; Hani Adamo; Lars Egevad; Torvald Granfors; Peter Hammarsten; Anders Bergh
Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.
The American journal of pathology 2011;179(4):1961-8.
2011: Daniel W Lin; Elaine A Ostrander; Ziding Feng; Liesel M FitzGerald; Rong Fu; Henrik Grönberg; William B Isaacs; Suzanne Kolb; Erika M Kwon; Pär Stattin; Fredrik Wiklund; Jianfeng Xu; Siqun Lilly Zheng; Janet L Stanford
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(9):1928-36.
2011: Anna Bill-Axelson; Ola Bratt; Hans Garmo; Mats Lambe; Ullakarin Nyberg; Pär Stattin; Jan Adolfsson; Gunnar Steineck
Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe Sweden.
European journal of cancer (Oxford, England : 1990) 2011;47(14):2195-201.
2011: Marcus Thomasson; Baofeng Wang; Peter Hammarsten; Anna Dahlman; Jenny Liao Persson; Andreas Josefsson; Pär Stattin; Torvald Granfors; Lars Egevad; Roger Henriksson; Anders Bergh; Håkan Hedman
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
International journal of cancer. Journal international du cancer 2011;128(12):2843-52.
2011: Martin Almquist; Dorthe Johansen; Tone Björge; Hanno Ulmer; Björn Lindkvist; Tanja Stocks; Göran Hallmans; Anders Engeland; Kilian Rapp; Håkan Jonsson; Randi Selmer; Guenter Diem; Christel Häggström; Steinar Tretli; Pär Stattin; Jonas Manjer
Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can).
Cancer causes & control : CCC 2011;22(5):743-51.
2011: Christel Häggström; Tanja Stocks; Kilian Rapp; Tone Bjørge; Björn Lindkvist; Hans Concin; Anders Engeland; Jonas Manjer; Hanno Ulmer; Randi Selmer; Steinar Tretli; Göran Hallmans; Håkan Jonsson; Pär Stattin
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
International journal of cancer. Journal international du cancer 2011;128(8):1890-8.
2011: Pär Stattin
Commentary: Fatherhood status and prostate cancer risk--the jury is still out.
International journal of epidemiology 2011;40(2):488.
2011: Anders Berglund; Hans Garmo; Carol Tishelman; Lars Holmberg; Pär Stattin; Mats Lambe
Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden.
The Journal of urology 2011;185(3):833-9.
2011: Wegene Borena; Tanja Stocks; Håkan Jonsson; Susanne Strohmaier; Gabriele Nagel; Tone Bjørge; Jonas Manjer; Göran Hallmans; Randi Selmer; Martin Almquist; Christel Häggström; Anders Engeland; Steinar Tretli; Hans Concin; Alexander Strasak; Pär Stattin; Hanno Ulmer
Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study.
Cancer causes & control : CCC 2011;22(2):291-9.
2011: Emma Hörnberg; Erik Bovinder Ylitalo; Sead Crnalic; Henrik Antti; Pär Stattin; Anders Widmark; Anders Bergh; Pernilla Wikström
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
PloS one 2011;6(4):e19059.
2011: Katarina Stenman; Pär Stattin; Hans Stenlund; Katrine Riklund; Gerhard Gröbner; Anders Bergh
H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples.
Biomarker insights 2011;6():39-47.
2010: Fredrik E Wiklund; Anna M Bennet; Patrik K E Magnusson; Ulrika K Eriksson; Fredrik Lindmark; Liyun Wu; Nasreen Yaghoutyfam; Christopher P Marquis; Pär Stattin; Nancy L Pedersen; Hans-Olov Adami; Henrik Grönberg; Samuel N Breit; David A Brown
Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality.
Aging cell 2010;9(6):1057-64.
2010: Ola Bratt; Anders Berglund; Jan Adolfsson; Jan-Erik Johansson; Magnus Törnblom; Pär Stattin
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
Scandinavian journal of urology and nephrology 2010;44(6):384-90.
2010: Benny Holmström; Erik Holmberg; Lars Egevad; Jan Adolfsson; Jan-Erik Johansson; Jonas Hugosson; Pär Stattin
Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study.
The Journal of urology 2010;184(4):1322-7.
2010: Tanja Stocks; Maria-Pia Hergens; Anders Englund; Weimin Ye; Pär Stattin
Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort.
International journal of cancer. Journal international du cancer 2010;127(7):1660-8.
2010: Pär Stattin; Hans Garmo; G Steineck; Anna Bill-Axelson
Re: Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.
Journal of the National Cancer Institute 2010;102(18):1447-8; author reply 1448.
2010: Ola Bratt; Hans Garmo; Jan Adolfsson; Anna Bill-Axelson; Lars Holmberg; Mats Lambe; Pär Stattin
Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
Journal of the National Cancer Institute 2010;102(17):1336-43.
2010: Dorthe Johansen; Tanja Stocks; Håkan Jonsson; Björn Lindkvist; Tone Björge; Hans Concin; Martin Almquist; Christel Häggström; Anders Engeland; Hanno Ulmer; Göran Hallmans; Randi Selmer; Gabriele Nagel; Steinar Tretli; Pär Stattin; Jonas Manjer
Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(9):2307-17.
2010: Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.
The American journal of pathology 2010;177(2):1031-41.
2010: Ingegerd Johansson; Bethany Van Guelpen; Johan Hultdin; Johansson Mattias; Göran Hallmans; Pär Stattin
Validity of food frequency questionnaire estimated intakes of folate and other B vitamins in a region without folic acid fortification.
European journal of clinical nutrition 2010;64(8):905-13.
2010: Mieke Van Hemelrijck; Hans Garmo; Lars Holmberg; Erik Ingelsson; Ola Bratt; Anna Bill-Axelson; Mats Lambe; Pär Stattin; Jan Adolfsson
Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(21):3448-56.
2010: Pär Stattin; Erik Holmberg; Jan-Erik Johansson; Lars Holmberg; Jan Adolfsson; Jonas Hugosson
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.
Journal of the National Cancer Institute 2010;102(13):950-8.
2010: Tone Bjørge; Annekatrin Lukanova; Håkan Jonsson; Steinar Tretli; Hanno Ulmer; Jonas Manjer; Tanja Stocks; Randi Selmer; Gabriele Nagel; Martin Almquist; Hans Concin; Göran Hallmans; Christel Häggström; Pär Stattin; Anders Engeland
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(7):1737-45.
2010: Tanja Stocks; Wegene Borena; Susanne Strohmaier; Tone Bjørge; Jonas Manjer; Anders Engeland; Dorthe Johansen; Randi Selmer; Göran Hallmans; Kilian Rapp; Hans Concin; Håkan Jonsson; Hanno Ulmer; Pär Stattin
Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can).
International journal of epidemiology 2010;39(3):660-7.
2010: Robert J. Klein; Christer Halldén; Angel M Cronin; Alexander Ploner; Fredrik Wiklund; Anders S Bjartell; Pär Stattin; Jianfeng Xu; Peter T Scardino; Kenneth Offit; Andrew J Vickers; Henrik Grönberg; Hans Lilja
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
Cancer prevention research (Philadelphia, Pa.) 2010;3(5):611-9.
2010: Mieke Van Hemelrijck; Jan Adolfsson; Hans Garmo; Anna Bill-Axelson; Ola Bratt; Erik Ingelsson; Mats Lambe; Pär Stattin; Lars Holmberg
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden.
The lancet oncology 2010;11(5):450-8.
2010: Tone Bjørge; Tanja Stocks; Annekatrin Lukanova; Steinar Tretli; Randi Selmer; Jonas Manjer; Kilian Rapp; Hanno Ulmer; Martin Almquist; Hans Concin; Göran Hallmans; Håkan Jonsson; Pär Stattin; Anders Engeland
Metabolic syndrome and endometrial carcinoma.
American journal of epidemiology 2010;171(8):892-902.
2010: Sara Lindström; David J Hunter; Henrik Grönberg; Pär Stattin; Fredrik Wiklund; Jianfeng Xu; STEPHEN CHANOCK; Richard Hayes; Peter Kraft
Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(3):873-6.
2010: Rudolf Kaaks; Pär Stattin
Obesity, endogenous hormone metabolism, and prostate cancer risk: a conundrum of "highs" and "lows".
Cancer prevention research (Philadelphia, Pa.) 2010;3(3):259-62.
2010: Anna Bill-Axelson; Hans Garmo; Mats Lambe; Ola Bratt; Jan Adolfsson; Ullakarin Nyberg; Gunnar Steineck; Pär Stattin
Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.
European urology 2010;57(3):390-5.
2010: Benny Holmström; Mattias Johansson; Ola Bratt; Pär Stattin
[The PSA test does not hold for screening. Good--but not good enough].
Läkartidningen 2010;107(7):436, 438-9.
2010: Peter Hammarsten; Amar Karalija; Andreas Josefsson; Stina Häggström Rudolfsson; Pernilla Wikström; Lars Egevad; Torvald Granfors; Pär Stattin; Anders Bergh
Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(4):1245-55.
2010: Jianfeng Xu; S Lilly Zheng; Sarah D Isaacs; Kathy E Wiley; Fredrik Wiklund; Jielin Sun; A Karim Kader; Ge Li; Lina D Purcell; Seong-Tae Kim; Fang-Chi Hsu; Pär Stattin; Jonas Hugosson; Jan Adolfsson; Patrick C Walsh; Jeffrey M. Trent; David Duggan; John D Carpten; Henrik Grönberg; William B Isaacs
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(5):2136-40.
2010: Elin Thysell; Izabella Surowiec; Emma Hörnberg; Sead Crnalic; Anders Widmark; Annika I Johansson; Pär Stattin; Anders Bergh; Thomas Moritz; Henrik Antti; Pernilla Wikström
Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.
PloS one 2010;5(12):e14175.
2010: L Thors; Anders Bergh; Emma Persson; Peter Hammarsten; Pär Stattin; Lars Egevad; Torvald Granfors; Christopher J Fowler
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.
PloS one 2010;5(8):e12275.
2010: Christina Hägglöf; Peter Hammarsten; AM Josefsson; Pär Stattin; Janna Paulsson; Anders Bergh; Arne Ostman
Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
PloS one 2010;5(5):e10747.
2009: Tanja Stocks; Kilian Rapp; Tone Bjørge; Jonas Manjer; Hanno Ulmer; Randi Selmer; Annekatrin Lukanova; Dorthe Johansen; Hans Concin; Steinar Tretli; Göran Hallmans; Håkan Jonsson; Pär Stattin
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.
PLoS medicine 2009;6(12):e1000201.
2009: Katarina Stenman; Jón B Hauksson; Gerhard Gröbner; Pär Stattin; Anders Bergh; Katrine Riklund
Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy.
Magma (New York, N.Y.) 2009;22(6):327-31.
2009: David A Brown; Fredrik Lindmark; Pär Stattin; Katarina Bälter; Hans-Olov Adami; Sigun L Zheng; Jianfeng Xu; William B Isaacs; Henrik Grönberg; Samuel N Breit; Fredrik E Wiklund
Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(21):6658-64.
2009: Mattias Johansson; James D McKay; Sabina Rinaldi; Fredrik Wiklund; Hans-Olov Adami; Henrik Grönberg; Rudolf Kaaks; Pär Stattin
Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
The Prostate 2009;69(12):1281-91.
2009: Sara Lindström; Hans-Olov Adami; Katarina Augustsson Bälter; Jianfeng Xu; S Lilly Zheng; Jielin Sun; Pär Stattin; Henrik Grönberg; Fredrik Wiklund
Genetic variation in the upstream region of ERG and prostate cancer.
Cancer causes & control : CCC 2009;20(7):1173-80.
2009: Rudolf Kaaks; Pär Stattin; Stéphanie Villar; Anna R Poetsch; Laure Dossus; Alexandra Nieters; Elio Riboli; Richard Palmqvist; Göran Hallmans; Christoph Plass; Marlin Friesen
Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort.
Cancer research 2009;69(13):5400-5.
2009: Katsiaryna Holl; Eva Lundin; Heljä-Marja Surcel; Kjell Grankvist; Pentti Koskela; Joakim Dillner; Göran Hallmans; Göran Wadell; Gudridur H Olafsdottir; Helga M Ogmundsdottir; Eero Pukkala; Matti Lehtinen; Pär Stattin; Annekatrin Lukanova
Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.
International journal of cancer. Journal international du cancer 2009;124(12):2923-8.
2009: Jouko Tuomisto; Katsiaryna Holl; Panu Rantakokko; Pentti Koskela; Göran Hallmans; Göran Wadell; Pär Stattin; Joakim Dillner; Helga M Ogmundsdottir; Terttu Vartiainen; Matti Lehtinen; Eero Pukkala
Maternal smoking during pregnancy and testicular cancer in the sons: a nested case-control study and a meta-analysis.
European journal of cancer (Oxford, England : 1990) 2009;45(9):1640-8.
2009: Pernilla Wikström; Josip Marusic; Pär Stattin; Anders Bergh
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
The Prostate 2009;69(8):799-809.
2009: Fredrik E Wiklund; Hans-Olov Adami; S Lilly Zheng; Pär Stattin; William B Isaacs; Henrik Grönberg; Jianfeng Xu
Established prostate cancer susceptibility variants are not associated with disease outcome.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1659-62.
2009: Mattias Johansson; James D McKay; Fredrik Wiklund; Sabina Rinaldi; Göran Hallmans; Katarina Bälter; Hans-Olov Adami; Henrik Grönberg; Pär Stattin; Rudolf Kaaks
Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1644-50.
2009: Mattias Johansson; Bethany Van Guelpen; Stein Emil Vollset; Johan Hultdin; Anders Bergh; Tim Key; Oivind Midttun; Göran Hallmans; Per Magne Ueland; Pär Stattin
One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1538-43.
2009: Fang-Chi Hsu; Jielin Sun; Fredrik Wiklund; Sarah D Isaacs; Kathy E Wiley; Lina D Purcell; Zhengrong Gao; Pär Stattin; Yi Zhu; Seong-Tae Kim; Zheng Zhang; Wennuan Liu; Bao-Li Chang; Patrick C Walsh; David Duggan; John D Carpten; William B Isaacs; Henrik Grönberg; Jianfeng Xu; S Lilly Zheng
A novel prostate cancer susceptibility locus at 19q13.
Cancer research 2009;69(7):2720-3.
2009: Wennuan Liu; Jishan Sun; Ge Li; Yi Zhu; Scott Zhang; Seong-Tae Kim; Jielin Sun; Fredrik Wiklund; Kathy E Wiley; Sarah D Isaacs; Pär Stattin; Jianfeng Xu; David Duggan; John D Carpten; William B Isaacs; Henrik Grönberg; S Lilly Zheng; Bao-Li Chang
Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.
Cancer research 2009;69(6):2176-9.
2009: S Lilly Zheng; Jielin Sun; Fredrik Wiklund; Zhengrong Gao; Pär Stattin; Lina D Purcell; Hans-Olov Adami; Fang-Chi Hsu; Yi Zhu; Jan Adolfsson; Jan-Erik Johansson; Aubrey R Turner; Tamara S Adams; Wennuan Liu; David Duggan; John D Carpten; Bao-Li Chang; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1105-11.
2009: Sigrid Carlsson; Jan Adolfsson; Ola Bratt; Jan-Erik Johansson; Christer Ahlstrand; Erik Holmberg; Pär Stattin; Jonas Hugosson
Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden.
Scandinavian journal of urology and nephrology 2009;43(5):350-6.
2009: Eva Hagel; Hans Garmo; Anna Bill-Axelson; Ola Bratt; Jan-Erik Johansson; Jan Adolfsson; Mats Lambe; Pär Stattin
PCBaSe Sweden: a register-based resource for prostate cancer research.
Scandinavian journal of urology and nephrology 2009;43(5):342-9.
2009: Wegene Borena; Tanja Stocks; Susanne Strohmaier; Alexander Strasak; Jonas Manjer; Dorthe Johansen; Håkan Jonsson; Kilian Rapp; Hans Concin; Göran Hallmans; Pär Stattin; Hanno Ulmer
Long-term temporal trends in cardiovascular and metabolic risk factors.
Wiener klinische Wochenschrift 2009;121(19-20):623-30.
2009: Benny Holmström; Mattias Johansson; Anders Bergh; Ulf-Håkan Stenman; Göran Hallmans; Pär Stattin
Prostate specific antigen for early detection of prostate cancer: longitudinal study.
BMJ (Clinical research ed.) 2009;339():b3537.
2009: Jielin Sun; Siqun Lilly Zheng; Fredrik Wiklund; Sarah D Isaacs; Ge Li; Kathleen E Wiley; Seong-Tae Kim; Yi Zhu; Zheng Zhang; Fang-Chi Hsu; Aubrey R Turner; Pär Stattin; Wennuan Liu; Jin Woo Kim; David Duggan; John D Carpten; William B Isaacs; Henrik Grönberg; Jianfeng Xu; Bao-Li Chang
Sequence variants at 22q13 are associated with prostate cancer risk.
Cancer research 2009;69(1):10-5.
2008: Pär Stattin; Erik Holmberg; Ola Bratt; Jan Adolfsson; Jan-Erik Johansson; Jonas Hugosson
Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden.
The Journal of urology 2008;180(6):2423-9; discussion 2429-30.
2008: Jielin Sun; Bao-Li Chang; Sarah D Isaacs; Kathy E Wiley; Fredrik Wiklund; Pär Stattin; David Duggan; John D Carpten; Bruce J Trock; Alan W Partin; Patrick C Walsh; Henrik Grönberg; Jianfeng Xu; William B Isaacs; S Lilly Zheng
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
The Prostate 2008;68(12):1257-62.
2008: Sara Wirén; Pär Stattin
Androgens and prostate cancer risk.
Best practice & research. Clinical endocrinology & metabolism 2008;22(4):601-13.
2008: Fang-Chi Hsu; Sara Lindström; Jielin Sun; Fredrik Wiklund; Shyh-Huei Chen; Hans-Olov Adami; Aubrey R Turner; Wennuan Liu; Katarina Bälter; Jin Woo Kim; Pär Stattin; Bao-Li Chang; William B Isaacs; Jianfeng Xu; Henrik Grönberg; S Lilly Zheng
A multigenic approach to evaluating prostate cancer risk in a systematic replication study.
Cancer genetics and cytogenetics 2008;183(2):94-8.
2008: Mats Olsson; Sara Lindström; Benjamin Häggkvist; Hans-Olov Adami; Katarina Augustsson Bälter; Pär Stattin; B Ask; Anders Rane; Lena Ekström; Henrik Grönberg
The UGT2B17 gene deletion is not associated with prostate cancer risk.
The Prostate 2008;68(5):571-5.
2008: S Lilly Zheng; Jielin Sun; Fredrik Wiklund; Shelly Smith; Pär Stattin; Ge Li; Hans-Olov Adami; Fang-Chi Hsu; Yi Zhu; Katarina Augustsson Bälter; A Karim Kader; Aubrey R Turner; Wennuan Liu; Eugene R Bleecker; Deborah A Meyers; David Duggan; John D Carpten; Bao-Li Chang; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Cumulative association of five genetic variants with prostate cancer.
The New England journal of medicine 2008;358(9):910-9.
2008: David Robinson; Gabriel Sandblom; Robert Johansson; Hans Garmo; Pär Stattin; Sören Mommsen; Eberhard Varenhorst
Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase.
The Journal of urology 2008;179(1):117-22; discussion 122-3.
2007: Tanja Stocks; Bernt Lindahl; Pär Stattin
[Healthy life style seems to reduce the risk of cancer. New support for the hypothesis that overweight and high blood glucose increase the cancer risk].
Läkartidningen 2007;104(51-52):3867-70.
2007: Johansson Mattias; James D McKay; Fredrik Wiklund; Sabina Rinaldi; Martijn Verheus; Carla H van Gils; Göran Hallmans; Katarina Augustsson Bälter; Hans-Olov Adami; Henrik Grönberg; Pär Stattin; Rudolf Kaaks
Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.
The Journal of clinical endocrinology and metabolism 2007;92(12):4820-6.
2007: Johansson Mattias; Bethany Van Guelpen; Johan Hultdin; Fredrik Wiklund; Hans-Olov Adami; Katarina Augustsson Bälter; Henrik Grönberg; Pär Stattin
The MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS study.
Cancer causes & control : CCC 2007;18(10):1169-74.
2007: Sara Lindström; Hans-Olov Adami; Katarina Augustsson Bälter; Jianfeng Xu; S Lilly Zheng; Pär Stattin; Henrik Grönberg; Fredrik Wiklund
Inherited variation in hormone-regulating genes and prostate cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):5156-61.
2007: Pernilla Wikström; Nina Ohlson; Pär Stattin; Anders Bergh
Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.
The Prostate 2007;67(12):1277-84.
2007: Annika Lundstig; Pär Stattin; Kenneth Persson; Kestutis Sasnauskas; Raphael P Viscidi; Randi Gislefoss; Joakim Dillner
No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.
International journal of cancer. Journal international du cancer 2007;121(5):1098-102.
2007: Sara Wirén; Tanja Stocks; Sabina Rinaldi; Göran Hallmans; Anders Bergh; Ulf-Hakan Stenman; Rudolf Kaaks; Pär Stattin
Androgens and prostate cancer risk: a prospective study.
The Prostate 2007;67(11):1230-7.
2007: Asa Skytt; Elin Thysell; Pär Stattin; Ulf-Hakan Stenman; Henrik Antti; Pernilla Wikström
SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
International journal of cancer. Journal international du cancer 2007;121(3):615-20.
2007: Tanja Stocks; Annekatrin Lukanova; Sabina Rinaldi; Carine Biessy; Laure Dossus; Bernt Lindahl; Göran Hallmans; Rudolf Kaaks; Pär Stattin
Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.
International journal of cancer. Journal international du cancer 2007;120(12):2678-86.
2007: Suvi Torniainen; Maria Hedelin; Ville Autio; Heli Rasinperä; Katarina Augustsson Bälter; Asa Klint; Rino Bellocco; Fredrik Wiklund; Pär Stattin; Tarja Ikonen; Teuvo L J Tammela; Johanna Schleutker; Henrik Grönberg; Irma Järvelä
Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):956-61.
2007: Katja Adolf; Ludwig Wagner; Anders Bergh; Pär Stattin; Peter Ottosen; Michael Borre; Karin Birkenkamp-Demtröder; Torben F Orntoft; Niels Tørring
Secretagogin is a new neuroendocrine marker in the human prostate.
The Prostate 2007;67(5):472-84.
2007: Pär Stattin; Ove Björ; Pietro Ferrari; Annekatrin Lukanova; Per Lenner; Bernt Lindahl; Göran Hallmans; Rudolf Kaaks
Prospective study of hyperglycemia and cancer risk.
Diabetes care 2007;30(3):561-7.
2007: Johansson Mattias; James D McKay; Pär Stattin; Federico Canzian; Catherine Boillot; Fredrik Wiklund; Hans-Olov Adami; Katarina Augustsson Bälter; Henrik Grönberg; Rudolf Kaaks
Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.
International journal of cancer. Journal international du cancer 2007;120(3):539-42.
2007: Jan Adolfsson; Hans Garmo; Eberhard Varenhorst; Göran Ahlgren; Christer Ahlstrand; Ove Andrén; Anna Bill-Axelson; Ola Bratt; Jan-Erik Damber; Karin Hellström; Magnus Hellström; Erik Holmberg; Lars Holmberg; Jonas Hugosson; Jan-Erik Johansson; Bill Petterson; Magnus Törnblom; Anders Widmark; Pär Stattin
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Scandinavian journal of urology and nephrology 2007;41(6):456-77.
2007: Eero Pukkala; Aage Andersen; Göran Berglund; Randi Gislefoss; Vilmundur Gudnason; Göran Hallmans; Egil Jellum; Pekka Jousilahti; Paul Knekt; Pentti Koskela; Pentti Kyyrönen; Per Lenner; Tapio Luostarinen; Arthur Löve; Helga M Ogmundsdóttir; Pär Stattin; Leena Tenkanen; Laufey Tryggvadóttir; Jarmo Virtamo; Göran Wadell; Anders Widell; Matti Lehtinen; Joakim Dillner
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
Acta oncologica (Stockholm, Sweden) 2007;46(3):286-307.
2007: James D McKay; Rudolf Kaaks; Johansson Mattias; Carine Biessy; Fredrik Wiklund; Katarina Augustsson Bälter; Hans-Olov Adami; Catherine Boillot; Lydie Gioia-Patricola; Federico Canzian; Pär Stattin; Henrik Grönberg
Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):169-73.
2007: Nina Ohlson; Anders Bergh; Pär Stattin; Pernilla Wikström
Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels.
The Prostate 2007;67(1):32-40.
2006: Anne Zeleniuch-Jacquotte; Eva Lundin; Andrea Micheli; Karen L Koenig; Per Lenner; Paola Muti; Roy E Shore; Ingegerd Johansson; Vittorio Krogh; Annekatrin Lukanova; Pär Stattin; Yelena Afanasyeva; Sabina Rinaldi; Alan A Arslan; Rudolf Kaaks; Franco Berrino; Göran Hallmans; Paolo Toniolo; Herman Adlercreutz
Circulating enterolactone and risk of endometrial cancer.
International journal of cancer. Journal international du cancer 2006;119(10):2376-81.
2006: Kelly J Hunt; Annekatrin Lukanova; Sabina Rinaldi; Eva Lundin; Teresa Norat; Richard Palmqvist; Pär Stattin; Elio Riboli; Göran Hallmans; Rudolf Kaaks
A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
Annals of epidemiology 2006;16(7):563-71.
2006: Nina Ohlson; Anders Bergh; Katarina Nygren; Pär Stattin; Pernilla Wikström
The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcome.
European urology 2006;49(4):675-83.
2006: Camilla Thellenberg-Karlsson; Sara Lindström; Beatrice Malmer; Fredrik Wiklund; Katarina Augustsson-Bälter; Hans-Olov Adami; Pär Stattin; Maria Nilsson; Karin Dahlman-Wright; Jan-�ke GUSTAFSSON; Henrik Grönberg
Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1936-41.
2006: Eberhard Varenhorst; Hans Garmo; Lars Holmberg; Pär Stattin; Jan-Erik Johansson
[Prostatic cancer in Sweden 1998-2003. Drastic change of the disease panorama].
Läkartidningen 2006;103(5):285-8.
2006: Annekatrin Lukanova; Stefan Söderberg; Rudolf Kaaks; Egil Jellum; Pär Stattin
Serum adiponectin is not associated with risk of colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(2):401-2.
2006: Bethany Van Guelpen; Sara M Wirén; Anders R J Bergh; Göran Hallmans; Pär Stattin; Johan Hultdin
Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2006;15(1):46-50.
2006: Annekatrin Lukanova; Ove Björ; Rudolf Kaaks; Per Lenner; Bernt Lindahl; Göran Hallmans; Pär Stattin
Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort.
International journal of cancer. Journal international du cancer 2006;118(2):458-66.
2005: Zoltan Korodi; Joakim Dillner; Egil Jellum; Sonja Lumme; Göran Hallmans; Steinar Thoresen; Timo Hakulinen; Pär Stattin; Tapio Luostarinen; Matti Lehtinen; Matti Hakama
Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(12):2952-5.
2005: Sabina Rinaldi; Paolo Toniolo; Paola Muti; Eva Lundin; Anne Zeleniuch-Jacquotte; Alan Arslan; Andrea Micheli; Per Lenner; Laure Dossus; Vittorio Krogh; Roy E Shore; Karen L Koenig; Elio Riboli; Pär Stattin; Franco Berrino; Göran Hallmans; Annekatrin Lukanova; Rudolf Kaaks
IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2005;14(6):493-6.
2005: Andreas Josefsson; Pernilla Wikström; Torvald Granfors; Lars Egevad; Lars Karlberg; Pär Stattin; Anders Bergh
Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment.
European urology 2005;48(4):577-83.
2005: Annika Bylund; Niina M Saarinen; Jie-Xian Zhang; Anders Bergh; Anders Widmark; Anders Johansson; Eva Lundin; Herman Adlercreutz; Göran Hallmans; Pär Stattin; Sari Mäkela
Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo.
Experimental biology and medicine (Maywood, N.J.) 2005;230(3):217-23.
2005: Nina Ohlson; Pernilla Wikström; Pär Stattin; Anders Bergh
Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment.
The Prostate 2005;62(4):307-15.
2005: Anna J Lind; Pernilla Wikström; Torvald Granfors; Lars Egevad; Pär Stattin; Anders Bergh
Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer.
The Prostate 2005;62(4):394-9.
2005: Johan Hultdin; Bethany Van Guelpen; Anders R J Bergh; Göran Hallmans; Pär Stattin
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.
International journal of cancer. Journal international du cancer 2005;113(5):819-24.
2005: Tarja Anttila; Leena Tenkanen; Sonja Lumme; Maija Leinonen; Randi Gislefoss; Göran Hallmans; Steinar Thoresen; Timo Hakulinen; Tapio Luostarinen; Pär Stattin; Pekka Saikku; Joakim Dillner; Matti Lehtinen; Matti Hakama
Chlamydial antibodies and risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):385-9.
2005: Pernilla Wikstrom; Annika Bylund; Jie-Xian Zhang; Göran Hallmans; Pär Stattin; Anders Bergh
Rye bran diet increases epithelial cell apoptosis and decreases epithelial cell volume in TRAMP (transgenic adenocarcinoma of the mouse prostate) tumors.
Nutrition and cancer 2005;53(1):111-6.
2005: Pär Stattin; Robert Johansson; Ronald Lodnert; Ove Andrén; Anna Bill-Axelsson; Ola Bratt; Jan-Erik Damber; Magnus Hellström; Jonas Hugosson; Rolf Lundgren; Magnus Törnblom; Eberhard Varenhorst; Jan-Erik Johansson
Geographical variation in incidence of prostate cancer in Sweden.
Scandinavian journal of urology and nephrology 2005;39(5):372-9.
2005: Eberhard Varenhorst; Hans Garmo; Lars Holmberg; Jan Adolfsson; Jan-Erik Damber; Magnus Hellström; Jonas Hugosson; Rolf Lundgren; Pär Stattin; Magnus Törnblom; Jan-Erik Johansson
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
Scandinavian journal of urology and nephrology 2005;39(2):117-23.
2005: Sabina Rinaldi; Rudolf Kaaks; Anne Zeleniuch-Jacquotte; Alan A Arslan; Roy E Shore; Karen L Koenig; Laure Dossus; Elio Riboli; Pär Stattin; Annekatrin Lukanova; Paolo Toniolo
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):48-52.
2004: Pär Stattin; Annika Bylund; Carine Biessy; Rudolf Kaaks; Göran Hallmans; Herman Adlercreutz
Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
Cancer causes & control : CCC 2004;15(10):1095-102.
2004: Fredrik Lindmark; S Lilly Zheng; Fredrik Wiklund; Jeannette T Bensen; Katarina Augustsson Bälter; Baoli Chang; Maria Hedelin; Jonathan Clark; Pär Stattin; Deborah A Meyers; Hans-Olov Adami; William B Isaacs; Henrik Grönberg; Jianfeng Xu
H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.
Journal of the National Cancer Institute 2004;96(16):1248-54.
2004: Sofia Halin; Pernilla Wikström; Stina Häggström Rudolfsson; Pär Stattin; Jennifer A Doll; Susan E Crawford; Anders Bergh
Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
Cancer research 2004;64(16):5664-71.
2004: Pär Stattin; Stefan Söderberg; Carine Biessy; Per Lenner; Göran Hallmans; Rudolf Kaaks; Tommy Olsson
Plasma leptin and breast cancer risk: a prospective study in northern Sweden.
Breast cancer research and treatment 2004;86(3):191-6.
2004: Pär Stattin; Sabina Rinaldi; Carine Biessy; Ulf-Hakan Stenman; Göran Hallmans; Rudolf Kaaks
High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3104-12.
2004: Fredrik Lindmark; Björn-Anders Jonsson; Anders Bergh; Pär Stattin; S Lilly Zheng; Deborah A Meyers; Jianfeng Xu; Henrik Grönberg
Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.
The Prostate 2004;59(2):132-40.
2004: Björn-Anders Jonsson; Hans-Olov Adami; Maria Hägglund; Anders Bergh; Ingela Göransson; Pär Stattin; Fredrik Wiklund; Henrik Grönberg
-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer.
International journal of cancer. Journal international du cancer 2004;109(3):348-52.
2004: Pär Stattin; Annekatrin Lukanova; Carine Biessy; Stefan Söderberg; Richard Palmqvist; Rudolf Kaaks; Tommy Olsson; Egil Jellum
Obesity and colon cancer: does leptin provide a link?
International journal of cancer. Journal international du cancer 2004;109(1):149-52.
2004: Annekatrin Lukanova; Eva Lundin; Anne Zeleniuch-Jacquotte; Paola Muti; A Mure; Sabina Rinaldi; Laure Dossus; Andrea Micheli; Alan Arslan; Per Lenner; Roy E Shore; Vittorio Krogh; Karen L Koenig; Elio Riboli; Franco Berrino; Göran Hallmans; Pär Stattin; Paolo Toniolo; Rudolf Kaaks
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(2):161-71.
2004: Annekatrin Lukanova; Eva Lundin; Andrea Micheli; Alan Arslan; Pietro Ferrari; Sabina Rinaldi; Vittorio Krogh; Per Lenner; Roy E Shore; Carine Biessy; Paola Muti; Elio Riboli; Karen L Koenig; Mortimer Levitz; Pär Stattin; Franco Berrino; Göran Hallmans; Rudolf Kaaks; Paolo Toniolo; Anne Zeleniuch-Jacquotte
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
International journal of cancer. Journal international du cancer 2004;108(3):425-32.
2004: Pär Stattin; Sonja Lumme; Leena Tenkanen; Henrik Alfthan; Egil Jellum; Göran Hallmans; Steinar Thoresen; Timo Hakulinen; Tapio Luostarinen; Matti Lehtinen; Joakim Dillner; Ulf-Hakan Stenman; Matti Hakama
High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
International journal of cancer. Journal international du cancer 2004;108(3):418-24.
2004: Annekatrin Lukanova; Anne Zeleniuch-Jacquotte; Eva Lundin; Andrea Micheli; Alan A Arslan; Sabina Rinaldi; Paola Muti; Per Lenner; Karen L Koenig; Carine Biessy; Vittorio Krogh; Elio Riboli; Roy E Shore; Pär Stattin; Franco Berrino; Göran Hallmans; Paolo Toniolo; Rudolf Kaaks
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
International journal of cancer. Journal international du cancer 2004;108(2):262-8.
2004: Pentti Tuohimaa; Leena Tenkanen; Merja H Ahonen; Sonja Lumme; Egil Jellum; Göran Hallmans; Pär Stattin; Sverre Harvei; Timo Hakulinen; Tapio Luostarinen; Joakim Dillner; Matti Lehtinen; Matti Hakama
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.
International journal of cancer. Journal international du cancer 2004;108(1):104-8.
2003: Pär Stattin; Richard Palmqvist; Stefan Söderberg; Carine Biessy; Bjarne Ardnor; Göran Hallmans; Rudolf Kaaks; Tommy Olsson
Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.
Oncology reports 2003;10(6):2015-21.
2003: Richard Palmqvist; Pär Stattin; Sabina Rinaldi; Carine Biessy; Roger Stenling; Elio Riboli; Göran Hallmans; Rudolf Kaaks
Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.
International journal of cancer. Journal international du cancer 2003;107(1):89-93.
2003: Annika Bylund; Eva Lundin; Jie-Xian Zhang; A Nordin; Rudolf Kaaks; Ulf-Hakan Stenman; Per Aman; Herman Adlercreutz; T K Nilsson; Göran Hallmans; Anders Bergh; Pär Stattin
Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2003;12(5):407-15.
2003: Rudolf Kaaks; Annekatrin Lukanova; Sabina Rinaldi; Carine Biessy; Stefan Söderberg; Tommy Olsson; Ulf-Hakan Stenman; Elio Riboli; Göran Hallmans; Pär Stattin
Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2003;12(4):309-15.
2003: Pär Stattin; Rudolf Kaaks
Re: Insulin resistance and prostate cancer risk.
Journal of the National Cancer Institute 2003;95(14):1086-7; author reply 1087.
2003: Pär Stattin; Matti Hakama
Correspondence re: B-L. Adam et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62: 3609-3614, 2002.
Cancer research 2003;63(10):2701; author reply 2701-2.
2003: Pär Stattin; Rudolf Kaaks; Robert Johansson; Randi Gislefoss; Stefan Söderberg; Henrik Alfthan; Ulf-Hakan Stenman; Egil Jellum; Tommy Olsson
Plasma leptin is not associated with prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(5):474-5.
2003: Göran Hallmans; Jie-Xian Zhang; Eva Lundin; Pär Stattin; Anders Johansson; Ingegerd Johansson; Kerstin Hultén; Anna Winkvist; Per Aman; Per Lenner; Herman Adlercreutz
Rye, lignans and human health.
The Proceedings of the Nutrition Society 2003;62(1):193-9.
2003: Pär Stattin; Robert Johansson; Jan-Erik Damber; Magnus Hellström; Jonas Hugosson; Rolf Lundgren; Eberhard Varenhorst; Jan-Erik Johansson
Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
Scandinavian journal of urology and nephrology 2003;37(6):461-5.
2003: Anders Rydh; Magnus Lundblad; Katrine Riklund Ahlström; Björn Tavelin; Pär Stattin
MRI of the skeleton in prostate cancer staging.
Scandinavian journal of urology and nephrology 2003;37(3):222-5.
2003: Björn Pilebro; Robert Johansson; Lena Damber; Jan-Erik Damber; Pär Stattin
Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.
Scandinavian journal of urology and nephrology 2003;37(3):210-2.
2002: Annekatrin Lukanova; Stefan Söderberg; Pär Stattin; Richard Palmqvist; Eva Lundin; Carine Biessy; Sabina Rinaldi; Elio Riboli; Göran Hallmans; Rudolf Kaaks
Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden).
Cancer causes & control : CCC 2002;13(6):509-16.
2002: Lars Egevad; Torvald Granfors; Lars Karlberg; Anders Bergh; Pär Stattin
Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection.
The Journal of urology 2002;168(2):509-13.
2002: Pernilla Wikström; Ingela Franck Lissbrant; Pär Stattin; Lars Egevad; Anders Bergh
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
The Prostate 2002;51(4):268-75.
2002: Pär Stattin; Herman Adlercreutz; Leena Tenkanen; Egil Jellum; Sonja Lumme; Göran Hallmans; Sverre Harvei; Lyly Teppo; Katariina Stumpf; Tapio Luostarinen; Matti Lehtinen; Joakim Dillner; Matti Hakama
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
International journal of cancer. Journal international du cancer 2002;99(1):124-9.
2002: Björn-Anders Jonsson; Anders Bergh; Pär Stattin; Monika Emmanuelsson; Henrik Grönberg
Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
International journal of cancer. Journal international du cancer 2002;98(6):838-43.
2002: Lars Egevad; Torvald Granfors; Lars Karlberg; Anders Bergh; Pär Stattin
Prognostic value of the Gleason score in prostate cancer.
BJU international 2002;89(6):538-42.
2002: Anders Bergh; Annika Bylund; Eva Lundin; Göran Hallmans; Pär Stattin
Transrectal core biopsy trauma may increase cell proliferation in prostate tumors.
Scandinavian journal of urology and nephrology 2002;36(4):311-3.
2001: Pär Stattin; Ulf-Hakan Stenman; Elio Riboli; Göran Hallmans; Rudolf Kaaks
Ratios of IGF-I, IGF binding protein-3, and prostate-specific antigen in prostate cancer detection.
The Journal of clinical endocrinology and metabolism 2001;86(12):5745-8.
2001: Annekatrin Lukanova; Paolo Toniolo; Arslan Akhmedkhanov; Kelly J Hunt; Sabina Rinaldi; Anne Zeleniuch-Jacquotte; N J Haley; Elio Riboli; Pär Stattin; Eva Lundin; Rudolf Kaaks
A cross-sectional study of IGF-I determinants in women.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2001;10(5):443-52.
2001: S Häggström; Pär Stattin; Pernilla Wikström; Anders Bergh; Jan-Erik Damber
Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancer.
BJU international 2001;88(1):110-6.
2001: Pär Stattin; Pernilla Wikström; Anders Bergh; Jan-Erik Damber
Gonadotropin-releasing hormone receptor expression in the human prostate.
The Prostate 2001;47(4):276-84.
2001: Pär Stattin; Sabina Rinaldi; Ulf-Hakan Stenman; Elio Riboli; Göran Hallmans; Anders Bergh; Rudolf Kaaks
Plasma prolactin and prostate cancer risk: A prospective study.
International journal of cancer. Journal international du cancer 2001;92(3):463-5.
2001: Pär Stattin; R Kaaks; Elio Riboli; P Ferrari; H Dechaud; Göran Hallmans
Circulating insulin-like growth factor-I and benign prostatic hyperplasia--a prospective study.
Scandinavian journal of urology and nephrology 2001;35(2):122-6.
2001: Pär Stattin; Stefan Söderberg; Göran Hallmans; Annika Bylund; Rudolf Kaaks; Ulf-Hakan Stenman; Anders Bergh; Tommy Olsson
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
The Journal of clinical endocrinology and metabolism 2001;86(3):1341-5.
2001: Börje Ljungberg; B Bozoky; G Kovacs; Pär Stattin; E Farrelly; Karin Nylander; Göran Landberg
p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
Scandinavian journal of urology and nephrology 2001;35(1):15-20.
2000: Pär Stattin; Annika Bylund; Sabina Rinaldi; Carine Biessy; Henri Déchaud; Ulf-Hakan Stenman; L Egevad; Elio Riboli; Göran Hallmans; Rudolf Kaaks
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Journal of the National Cancer Institute 2000;92(23):1910-7.
2000: Ingela Franck Lissbrant; Pär Stattin; P Wikstrom; Jan-Erik Damber; Lars Egevad; Anders Bergh
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival.
International journal of oncology 2000;17(3):445-51.
2000: Pernilla Wikström; Per Wikström; Ingela Franck Lissbrant; Anders Bergh; Jan-Erik Damber; Pär Stattin
Evaluation of prognostic factors in prostate cancer with partial least squares analysis.
Scandinavian journal of urology and nephrology 2000;34(4):252-6.
1999: P Wikström; P Westin; Pär Stattin; Jan-Erik Damber; Anders Bergh
Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients.
The Prostate 1999;38(4):268-77.
1998: Annika Bylund; Pär Stattin; Anders Widmark; Anders Bergh
Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;49(2):143-8.
1998: Pernilla Wikström; Pär Stattin; Ingela Franck Lissbrant; Jan-Erik Damber; Anders Bergh
Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.
The Prostate 1998;37(1):19-29.
1998: Pär Stattin; P Westin; Jan-Erik Damber; Anders Bergh
Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer.
British journal of cancer 1998;77(4):670-5.
1997: Ingela Franck Lissbrant; Pär Stattin; Jan-Erik Damber; Anders Bergh
Vascular density is a predictor of cancer-specific survival in prostatic carcinoma.
The Prostate 1997;33(1):38-45.
1997: Pär Stattin; Anders Bergh; Lars Karlberg; Björn Tavelin; Jan-Erik Damber
Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancer.
European urology 1997;32(4):404-9.
1997: Pär Stattin
Prognostic factors in prostate cancer.
Scandinavian journal of urology and nephrology. Supplementum 1997;185():1-46.
1997: Pär Stattin; Jan-Erik Damber; Lars Karlberg; Anders Bergh
Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer.
The Journal of urology 1997;157(1):219-22.
1996: Pär Stattin; Jan-Erik Damber; Hans Modig; Anders Bergh
Pretreatment p53 immunoreactivity does not infer radioresistance in prostate cancer patients.
International journal of radiation oncology, biology, physics 1996;35(5):885-9.
1996: Pär Stattin; Lars Karlberg; Jan-Erik Damber
Long-term outcome of patients treated for hydrocele with the sclerosant agent sodium tetradecyl sulphate.
Scandinavian journal of urology and nephrology 1996;30(2):109-13.
1996: Pär Stattin; Jan-Erik Damber; Lars Karlberg; H Nordgren; Anders Bergh
Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival.
Urological research 1996;24(5):257-64.
1996: Pär Stattin; Anders Bergh; Lars Karlberg; H Nordgren; Jan-Erik Damber
p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer.
European urology 1996;30(1):65-72.
1995: P Westin; Pär Stattin; Jan-Erik Damber; Anders Bergh
Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.
The American journal of pathology 1995;146(6):1368-75.
1991: H Nordgren; S Nilsson; S Eklöv; Pär Stattin; W Naining; T Heiden; L Bergkvist; Lars Karlberg; C Lundholm; B Harvig
Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancer.
Acta oncologica (Stockholm, Sweden) 1991;30(2):211-4.